Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the ...
According to investigators, there is no validated PSA-based endpoint to compare oncologic outcomes after radical prostatectomy and radiation therapy for localized prostate cancer.
Nadofaragene firadenovec appears effective in real-world patients with bacillus Calmette-Guérin (BCG)-unresponsive nonmuscle-invasive bladder cancer ...
Real-world data support trial data on the use of lutetium-177 PSMA-617 in patients with PSMA-positive, metastatic castration-resistant prostate cancer.
“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...
The proportion of oncologists who were satisfied with their work-life integration decreased from 35% in 2013 to 24% in 2023. Burnout in US oncologists has increased over the past 10 years ...
The Food and Drug Administration (FDA) has approved Emblaveoâ„¢ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative ...
PSA doubling time is an essential criterion for high-risk biochemically recurrent prostate cancer that should prompt treatment escalation.
Proposed changes to HIPAA regulations are meant to strengthen cybersecurity protections for electronic protected health information.
(HealthDay News) — Surgeons at Massachusetts General Hospital have successfully performed the fourth pig kidney transplant in the US. The recipient of the genetically modified pig organ was a 66 ...
Opioid prescriptions in the emergency department linked to small increases in hospital admission and subsequent opioid prescription use. (HealthDay News) — Emergency department opioid ...
Pain intensity linked to increased likelihood of using cigarettes, e-cigarettes, cannabis, lower likelihood of alcohol use. (HealthDay News) — Among cancer survivors, pain is associated with an ...